Ingredient Highlight
Top-ranking Women's Health ingredients for October 2026
Women’s health continues to be one of the most active areas of ingredient research and product development. The five branded ingredients below are the top-ranking Women’s Health ingredients on NXT Ingredients®, based on Google Analytics activity across ingredient pages. Explore what formulators and brands are researching most, along with the clinical research, targeted benefits and formulation advantages behind each ingredient.
0
Pages visited SEPT 26
0 +
BRANDED Ingredients
0 +
Curcumin Ingredients
INGREDIENT 1
EstroG-100® from Naturalendo Tech
EstroG-100® by Naturalendo Tech Co gives formulators a clinically established, non-hormonal approach to menopause support. This patented blend of three botanical root extracts has been evaluated across multiple human clinical studies, with research demonstrating improvements in a broad range of menopausal symptoms. At 514 mg daily, EstroG-100® offers brands a well-researched option for comprehensive menopause formulations without altering circulating estrogen levels.
To learn more about EstroG-100® click here.
INGREDIENT 2
SheVari4® by Cepham
SheVari4® by Cepham gives formulators a more targeted approach to Shatavari for menopause support. Standardized to a minimum 5% Shatavarin IV and clinically studied at just 100 mg daily, SheVari4® has demonstrated improvements across multiple menopause-related symptoms. Its concentrated, low-dose format also leaves valuable formulation space for complementary ingredients, making it especially relevant for brands developing comprehensive menopause formulas.
To learn more about Shevari4® click here.
INGREDIENT 4
EquoYouth® from Bonarge
EquoYouth® by Bonerge gives formulators a precision approach to women’s healthy aging with high-purity S-equol, the biologically active form of equol. With >99% S-configuration purity, EquoYouth® moves the formulation conversation beyond traditional menopause positioning toward broader women’s health applications. Its clinically researched, low-dose profile makes it especially relevant for brands developing differentiated products across multiple stages of women’s health.
To learn more about EquoYouth® click here.
INGREDIENT 5
Xeya® From NXT-USA
Xeya™ by NXT-USA gives formulators a concentrated, low-dose Shatavari option for women’s health products across multiple life stages. Standardized to 15% shatavarins and clinically studied at 50–100 mg daily, Xeya™ provides substantial formulation flexibility compared with conventional higher-dose Shatavari extracts. Its low dose and clinical research make it particularly attractive for brands developing sophisticated multi-ingredient women’s health formulas.
To learn more about Xeya® click here.
INGREDIENT 5
Genopause® from Saanroo
Genopause® by Saanroo gives formulators a clinically researched botanical option developed specifically for women navigating menopause. Its research supports benefits across multiple menopause-related concerns, creating an opportunity to address the broader experience rather than a single symptom. For supplement brands developing comprehensive menopause products, Genopause® offers a differentiated, research-backed ingredient with relevance across several of the outcomes women are actively seeking.
To learn more about Genopause® click here.
Let’s discuss your project
Learn more about NXT Ingredients™ and how it can transform your brand development processes. Ask for ingredient samples, documents and more.